Sanofi Pasteur is allowed to sell ‘Menactra’ in Korea

Published: 2014-11-26 15:07:55

Updated: 2014-11-26 15:10:02

Sanofi Pasteur (president Regis Launay) announced that ‘Menactra’, a meningococcal (Groups A, C, Y and W-135) polysaccharide diphtheria toxoid conjugate vaccine, receivedmarketing authorization from the Ministry of Food and Drug Safety on the 21^st.

Menactra, the top-ranked drug (in sales)among other meningococcal conjugated protein vaccines, has been provided approximately 72 million doses in ...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.